Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism Sodium channels blockers |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H24N2O |
InChIKeyORSXUCINPRPFJL-UHFFFAOYSA-N |
CAS Registry1573094-73-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Myotonia | Preclinical | IT | 01 Feb 2017 |